Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cureus|May 22, 2023
Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group StudyElvina Almuradova, Suayib Yalcin, Rukiye Arıkan, et al.
Journal of Cancer Research and Therapeutics|July 5, 2018
Ventricular bigeminal rhythm associated with trastuzumab: A potential cardiac side effectMustafa Karaca, Hakan Kocoglu, Irem Bilgetekin, et al.
Journal of Cancer Research and Therapeutics|November 30, 2018
Ewing's sarcoma of kidney in a 60-year-old patient with local recurrence: A rare occurrenceIrem Bilgetekin, Mustafa Karaca, Ipek Işık Gönül, et al.
Current Oncology (Toronto, Ont.)|July 27, 2026
Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World StudyBeyza Ünlü, Hacer Demir, Sena Ece Davarcı, et al.
Croatian Medical Journal|July 1, 2023
The effect of high standard uptake value in lung cancer metastatic lesions on survivalSuphi Aydin, Aydın Balcı, Ahmet Dumanlı, et al.
European Journal of Clinical Pharmacology|February 19, 2025
Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? : IMDC in lung cancer immunotherapyİsmail Beypınar, Semiha Urvay, Müslih Ürün, et al.
Journal of Gastrointestinal Cancer|September 11, 2020
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG StudyIsmail Beypinar, Hacer Demir, Abdullah Sakin, et al.
The Prostate|April 8, 2026
Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate CancerAli Fuat Gürbüz, Murat Araz, Hacer Demir, et al.
American Journal of Cancer Research|July 16, 2025
Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumabOnur Yazdan Balçık, İsmail Beypınar, Semiha Urvay, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World StudyCanan Yıldız, Meltem Baykara, Hacer Demir, et al.
Pageof 6